Nurx Review: Which Women Should Avoid It (and Who It Actually Serves Well)
At a glance
- Platform type / Asynchronous + synchronous telehealth, cash and insurance
- Services covered / Birth control, HRT, PrEP, skin care, STI testing
- Prescribing states / Licensed in all 50 U.S. States (varies by service)
- Pregnancy safety / Cannot prescribe most contraindicated drugs in pregnancy; no obstetric care
- Life stage gap / Limited support for complex perimenopause or fertility workup
- BBB accreditation / Not BBB-accredited as of 2025; mixed consumer reviews
- LegitScript status / LegitScript-certified pharmacy partner network
- Insurance / Accepts most major plans; some services cash-only
- Who it serves best / Healthy women aged 18-45 needing routine contraception or skin Rx
- Biggest clinical gap / No in-office exam, limited lab follow-up protocols for HRT
Is Nurx a Legitimate Medical Service?
Nurx is a real, licensed telehealth company operating under state medical board oversight in the United States. Its prescribers hold valid state licenses, and its pharmacy partners are required to meet state dispensing laws. "legitimate" does not automatically mean "right for you," and several specific patient profiles face real clinical risk by relying on Nurx alone.
LegitScript, the pharmacy verification body used by Google and major ad networks, has certified Nurx's dispensing partners. The platform operates under the federal Ryan Haight Act framework for online prescribing, which requires a valid prescriber-patient relationship before controlled substances can be issued. Nurx does not prescribe controlled substances for most of its core service lines, which keeps it squarely within telemedicine rules.
The FDA's guidance on internet pharmacies notes that a valid prescription, a U.S.-licensed pharmacist, and a licensed prescriber are the three pillars of a safe online pharmacy. Nurx meets all three for the drug categories it covers.
What the BBB Record Actually Shows
Nurx is not accredited by the Better Business Bureau as of mid-2025. Consumer complaint patterns on the BBB and on Trustpilot cluster around billing errors, delayed shipments, and difficulty reaching customer service, not clinical harm from inappropriate prescribing. These are operational complaints, and they matter for your experience, but they are different from a safety record that would warrant avoiding the platform altogether.
How Prescriber Oversight Works
Each Nurx clinical encounter is reviewed asynchronously by a nurse practitioner or physician licensed in your state. The intake questionnaire is the clinical exam. For low-risk prescriptions like combined oral contraceptives in a healthy 24-year-old nonsmoker, that model is well-supported by evidence. The ACOG Practice Bulletin on combined hormonal contraceptives confirms that most healthy women do not require a pelvic exam or Pap smear before starting hormonal contraception, so asynchronous intake is clinically defensible for that population.
Specific Patient Profiles That Should Avoid Nurx
This is the section most review sites skip. Being blunt here serves you better than a vague "consult your doctor" disclaimer.
Women With Cardiovascular Risk Factors
Combined hormonal contraceptives, including the pill, patch, and ring, carry a two- to fourfold increased risk of venous thromboembolism (VTE) compared with non-users. That risk compounds with smoking, obesity (BMI <30 is not a contraindication, but BMI >35 with estrogen-containing methods raises concern), personal or family history of clotting disorders, hypertension above 140/90 mmHg, and migraine with aura.
Nurx's intake questionnaire screens for these factors and is designed to route high-risk patients away from estrogen-containing methods. The problem: an asynchronous text exchange cannot replace a blood pressure reading or a Factor V Leiden assay. If you have untreated hypertension, a personal history of DVT or PE, known thrombophilia, or migraine with aura, you need an in-person prescriber who can document and manage those findings longitudinally, not a one-time online questionnaire.
ACOG Practice Bulletin 206 explicitly classifies migraine with aura as a WHO Medical Eligibility Criteria Category 4 condition for combined hormonal contraceptives. That means the method is contraindicated. An asynchronous platform that misses or misclassifies this item creates real patient harm.
Women Over 40 Seeking HRT
Nurx offers hormone replacement therapy, and for women in straightforward early perimenopause without cardiovascular disease, it may be adequate. For women over 40 with any of the following, it is not:
- Unexplained vaginal bleeding
- Personal history of breast cancer, ovarian cancer, or endometrial cancer
- Active liver disease
- Uncontrolled hypertension
- Suspected cardiovascular disease
The Menopause Society's 2023 position statement states that "individualized risk-benefit assessment by a knowledgeable clinician is essential before initiating systemic hormone therapy." Asynchronous intake can capture a written history, but it cannot perform a breast exam, interpret a recent mammogram, or integrate a full cardiovascular risk score in real time. Women over 50 or those with a first-degree relative with breast cancer should work with a NAMS-certified menopause practitioner or OB-GYN for their HRT initiation.
A further issue: Nurx does not currently offer compounded bioidentical hormones or pellet therapy, which is a limitation some women notice. It prescribes FDA-approved HRT formulations only, which from a safety standpoint is actually the correct practice, since FDA-approved HRT formulations have established safety and efficacy data that compounded preparations lack.
Women With PCOS Who Need More Than Contraception
PCOS affects an estimated 8 to 13 percent of reproductive-age women worldwide. Nurx can prescribe combined oral contraceptives to manage PCOS-related irregular cycles and androgen excess, and for some women that is genuinely sufficient. The gap appears when PCOS management requires:
- Metabolic workup (fasting insulin, lipids, HbA1c)
- Metformin prescribing for insulin resistance
- Fertility evaluation and ovulation induction
- Weight management with GLP-1 agonists
- Dermatologic co-management for hirsutism or acne beyond topical treatment
Nurx does not currently offer metformin for PCOS, GLP-1 medications, or fertility services. A woman with PCOS who is trying to conceive, or who has significant metabolic comorbidities, needs a reproductive endocrinologist or a women's health NP with metabolic prescribing scope.
Women Who Are Pregnant or Trying to Conceive
Nurx does not provide obstetric care. This matters most for two scenarios.
If you are pregnant now: Stop any combined hormonal contraceptive immediately. Estrogen-containing contraceptives are contraindicated in pregnancy. If you became pregnant while using a Nurx-prescribed method, transition your care to an OB-GYN or certified nurse midwife without delay.
If you are actively trying to conceive: Most contraceptives prescribed by Nurx are by definition not compatible with conception attempts. Nurx does not prescribe fertility medications, order transvaginal ultrasound monitoring, or manage luteal phase support. For preconception planning, fertility workup, or ovulation induction, you need ASRM-affiliated reproductive medicine.
The ASRM Practice Committee is unambiguous that fertility management requires coordinated clinical and laboratory monitoring that cannot be replicated by asynchronous telehealth alone.
Women With a History of Certain Cancers
Estrogen-containing products are contraindicated or require extremely careful risk stratification in women with a personal history of hormone-receptor-positive breast cancer, endometrial cancer, or hepatocellular carcinoma. Nurx's intake questionnaire does ask about cancer history, and a positive screen should route you out of estrogen prescribing. The concern is with incomplete history disclosure or the nuanced case of a woman who is five years post-treatment with her oncologist's conditional approval. Those conversations require a physician who can speak with your oncology team directly.
Adolescents Under 18
Nurx is available to users 18 and older only. This is consistent with state telehealth prescribing regulations in most U.S. Jurisdictions. Adolescents seeking contraceptive or dermatologic care should work with their pediatrician or an adolescent medicine specialist who can address the full scope of reproductive and mental health needs at that life stage.
Where Nurx Genuinely Delivers Value
The following framework helps you decide whether Nurx fits your clinical situation. Think of it as a two-axis assessment: complexity of your medical history versus urgency of access.
Low complexity + high access barrier = strong Nurx fit. A 28-year-old woman in a rural county without a nearby OB-GYN, no significant medical history, no smoking, normal blood pressure, and a need for a progestin-only pill or combined oral contraceptive is an excellent candidate for Nurx. The alternative in some zip codes is no contraception at all.
Low complexity + low access barrier = optional Nurx fit. You could use Nurx for convenience, but a local clinician is also a reasonable choice. Nurx wins on speed and price transparency; a local clinician wins on longitudinal relationship.
High complexity + any access level = avoid Nurx. The clinical scenarios in the section above apply regardless of whether a specialist is nearby.
Birth Control: The Strongest Use Case
Combined oral contraceptives, progestin-only pills, the patch, the vaginal ring, and emergency contraception are the clearest wins for Nurx. Access to same-day contraception via telehealth reduces the gap between intent and use, which matters because nearly half of all U.S. Pregnancies remain unintended and contraceptive access barriers are a documented driver. Nurx accepts most major insurance plans and offers a cash-pay sliding scale, which broadens access for uninsured women.
PrEP for Women
Nurx is one of the few consumer telehealth platforms that actively prescribes PrEP (pre-exposure prophylaxis) for HIV prevention to women. Women account for approximately 19 percent of new HIV diagnoses in the United States, and PrEP uptake in women lags far behind uptake in men. Tenofovir disoproxil fumarate/emtricitabine (Truvada) and tenofovir alafenamide/emtricitabine (Descovy) are both FDA-approved for PrEP, though Descovy's approval does not extend to receptive vaginal sex, meaning Truvada remains the appropriate choice for most women. Nurx prescribes Truvada for eligible women and coordinates the required quarterly HIV and renal monitoring labs.
Skin Care: Topical Acne and Hormonal Acne
Nurx offers topical tretinoin, clindamycin phosphate, topical spironolactone, and oral spironolactone for acne. For women with hormonal acne, oral spironolactone at doses of 50 to 200 mg daily has strong evidence for androgen-mediated acne. This is a reasonable Nurx use case for women without hyperkalemia risk, renal disease, or concurrent ACE inhibitor use.
Pregnancy note on spironolactone: Spironolactone is absolutely contraindicated in pregnancy due to feminization risk to a male fetus. Animal data and mechanistic evidence support teratogenicity, and while large human cohort data are limited, the theoretical risk is sufficient that all women of reproductive age prescribed spironolactone must use reliable contraception concurrently. Nurx should, and does, prompt contraception use alongside spironolactone prescribing, but this is a point to confirm explicitly in your intake.
Pregnancy, Lactation, and Contraception: What Nurx Does and Does Not Cover
Pregnancy safety is a required consideration for every drug category Nurx prescribes. Here is the breakdown by service line.
Combined Hormonal Contraceptives
Combined estrogen-progestin methods are contraindicated in pregnancy. If you suspect pregnancy while using a Nurx-prescribed pill, patch, or ring, take a home pregnancy test and contact an OB-GYN immediately. Accidental first-trimester exposure to combined oral contraceptives has not been shown to cause structural fetal defects in large surveillance studies, but the method must be stopped. Nurx does not provide pregnancy confirmation or prenatal care.
During lactation, combined hormonal contraceptives may reduce milk supply, particularly in the early postpartum period before lactation is well established. ACOG and the CDC U.S. Medical Eligibility Criteria classify combined hormonal contraceptives as Category 2 (advantages generally outweigh risks) for breastfeeding women more than four weeks postpartum. For the first four weeks postpartum, they are Category 3 or 4 depending on breastfeeding status. Progestin-only methods, including the minipill, are preferred during lactation and are available through Nurx.
Spironolactone
Absolutely contraindicated in pregnancy. All women of childbearing potential prescribed spironolactone by Nurx must use a highly effective contraceptive method concurrently. Do not use spironolactone if you are pregnant, planning pregnancy in the near term, or breastfeeding without explicit guidance from your prescriber. Spironolactone passes into breast milk; the safety profile during lactation is not well established in human data.
Tretinoin (Topical)
Topical tretinoin at standard dermatologic doses carries a much lower systemic absorption risk than oral retinoids such as isotretinoin. FDA labeling for topical tretinoin notes that animal studies at high doses show teratogenicity, but human data on topical use have not demonstrated a clear teratogenic signal. The conservative recommendation is to discontinue topical tretinoin in confirmed pregnancy and restart only after delivery and cessation of breastfeeding. Nurx prescribes topical tretinoin, not oral isotretinoin, which is a meaningful safety distinction. Oral isotretinoin, the agent associated with severe teratogenicity, is not available through Nurx.
HRT
Systemic hormone therapy using estradiol and progestogen is contraindicated in pregnancy, though pregnancy in the natural-menopause population is extraordinarily rare. Women in perimenopause who retain ovulatory cycles can still conceive, and spontaneous conception has been documented in women in their late 40s and early 50s. If you are perimenopausal, on Nurx HRT, and have not confirmed natural menopause (defined as 12 consecutive months without a period), contraception remains relevant. Discuss this explicitly with your Nurx clinician.
Emergency Contraception
Levonorgestrel emergency contraception (Plan B and generics) is not abortifacient and is not effective if taken after implantation. It does not harm an established pregnancy. It is not appropriate for use as regular contraception. Nurx dispenses levonorgestrel EC; effectiveness is highest within 72 hours of unprotected sex and declines to approximately 58 percent at 73 to 120 hours. Body weight above 165 to 175 lb may reduce efficacy; ulipristal acetate (ella) or a copper IUD (not available via Nurx) are more effective alternatives in that population.
Life-Stage Guide to Nurx Use
Reproductive Years (18-39)
This is Nurx's core demographic. Healthy women in this age range with no significant comorbidities, seeking reliable contraception or skin care, are well-served by the platform. Ensure your blood pressure is under 140/90 mmHg before starting estrogen-containing contraception; Nurx cannot measure this for you.
Trying to Conceive (Any Age)
Nurx is not a fertility platform. It cannot order Day 3 FSH, antral follicle counts, or semen analysis. If conception is the goal, transition care to a reproductive endocrinologist or OB-GYN with fertility prescribing scope.
Postpartum and Lactating Women
Progestin-only options available through Nurx are appropriate for lactating women more than six weeks postpartum. Avoid combined hormonal methods before four weeks postpartum, and use them cautiously between four and six weeks if breastfeeding exclusively. Document your postpartum and breastfeeding status accurately in your Nurx intake.
Perimenopause (Typically 40-51)
Nurx HRT is an option for uncomplicated early perimenopause. Women with cardiovascular disease, prior breast cancer, unexplained bleeding, or significant metabolic disease need a NAMS-certified practitioner. The Menopause Society's MenoPro app and provider finder can locate a menopause-specialist clinician near you.
Post-Menopause (After 12 Months of Amenorrhea)
Post-menopausal women on long-term HRT need periodic reassessment of cardiovascular risk, mammography results, and bone density that cannot be conducted asynchronously. Annual follow-up with an in-person clinician is appropriate even if Nurx manages prescription refills.
What Nurx Complaints Actually Tell You
The most frequent consumer complaints about Nurx, based on aggregated BBB filings and app store reviews, fall into three categories:
Billing errors. Insurance billing discrepancies are the single most common complaint. If your insurance denies a claim, Nurx customer service response times have been cited as slow by multiple reviewers. Verify your coverage before ordering.
Shipment delays. Pharmacy processing and mail delivery delays are reported, particularly during high-demand periods. For time-sensitive needs like emergency contraception, a local pharmacy may be faster.
Difficulty changing prescriptions. Some users report friction when requesting a different formulation or dose. This is partly a function of asynchronous care: there is no appointment to call into and negotiate in real time. If your contraceptive needs are likely to require frequent adjustment, a synchronous telehealth visit or an in-person clinician may serve you better.
None of these complaints constitute evidence of unsafe clinical practice. They do constitute evidence of an operational model that works best for stable, predictable prescribing needs.
Nurx vs. In-Person Care: A Direct Comparison
| Factor | Nurx | In-Person OB-GYN or NP | |---|---|---| | Blood pressure measurement | You report it; not verified | Measured at every visit | | Physical exam | None | Available | | Lab ordering (HRT, PrEP) | Available for some services | Standard | | Formulary breadth | Limited to platform formulary | Full prescribing scope | | Fertility services | Not available | Available or referral | | Continuity of care | Asynchronous; no named clinician | Named clinician relationship | | Cost (uninsured) | Often lower | Often higher | | Access in rural areas | Available nationwide | May be limited | | Emergency or urgent care | Not available | Available |
Frequently asked questions
›Is Nurx legit?
›What are the most common Nurx complaints?
›Can Nurx prescribe birth control to someone with high blood pressure?
›Does Nurx prescribe HRT for menopause?
›Can I use Nurx if I have PCOS?
›Is Nurx safe during pregnancy?
›Can I use Nurx while breastfeeding?
›Does Nurx accept insurance?
›Can teenagers use Nurx?
›What happens if I need to change my birth control prescription on Nurx?
›Is spironolactone from Nurx safe?
›Does Nurx prescribe isotretinoin (Accutane)?
References
- ACOG Practice Bulletin 206: Combined Hormonal Contraceptives. American College of Obstetricians and Gynecologists, 2019.
- Lidegaard O, et al. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890.
- The Menopause Society 2023 Position Statement on Hormone Therapy. Menopause. 2023.
- March WA, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010.
- Kerns J, et al. Telehealth and contraceptive access. Am J Obstet Gynecol. 2020.
- Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med. 2016;374:843-852.
- CDC. HIV Among Women. Centers for Disease Control and Prevention.
- FDA. Descovy Approval Press Release. U.S. Food and Drug Administration, 2019.
- Roberts EE, et al. Spironolactone for acne vulgaris: a systematic review and meta-analysis. J Am Acad Dermatol. 2017.
- Spironolactone prescribing information. FDA Access Data. 2014.
- Tretinoin topical prescribing information. FDA Access Data. 2010.
- CDC U.S. Medical Eligibility Criteria for Contraceptive Use. Centers for Disease Control and Prevention, 2016.
- Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen for emergency contraception. Lancet. 1998.
- FDA. Menopause and Hormones: Common Questions. U.S. Food and Drug Administration.
- ASRM Practice Committee Documents. American Society for Reproductive Medicine.
- Jacobsson B, et al. Advanced maternal age and pregnancy outcomes. Hum Reprod. 2004.
- FDA. Buying Medicines Online. U.S. Food and Drug Administration.